Download PDF

Other users also viewed these articles

RIPK3 and kidney disease Juan Guerrero-Mauvecin; Miguel Fontecha-Barriuso; Ana M. López-Diaz; Alberto Ortiz; Ana B. Sanz;
Nefrologia (English Version). 2024;44:10-22
Improvement in the detection, diagnosis, and early treatment of chronic kidney disease in Spain. The IntERKit project José Luis Górriz; Fran Adán Gil; Manuel A. Botana López; Antonio Buño Soto; Francisco José Campos Cabrera; Angeles Cisneros; Silvia Cobo Guerrero; María Dolores Conejos; Isabel Egocheaga Cabello; M. Concepción Fernández Planelles; Lisardo García-Matarín; Natalia Jiménez; Juan Carlos Julián Mauro; David León Jiménez; Daniel Martínez Gamote; Pilar Mazón Ramos; Alberto Ortiz; Gemma Palau; Julia Quevedo Rivera; J. Emilio Sánchez-Álvarez; Rita Tristancho Ajamil; Cristina Varga Martín; Roser Vallés Fernández;
10.1016/j.nefroe.2025.05.001
Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease Mariana Morais David Pliças; Bernardo Marques da Silva; Edgar Avito Fernandes de Almeida;
Nefrologia (English Version). 2025;45:214-27